Ratio Therapeutics, Inc. — Form D

Ratio Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2026-07-31. The offering totals $70.0M, of which $70.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (22)

NameRoleLocation
John BabichRelated PersonBoston, MA
Marc BeckerRelated PersonBoston, MA
William CowanRelated PersonBoston, MA
Allan GreenRelated PersonBoston, MA
Albert HolmanRelated PersonBoston, MA
John W. HoppinRelated PersonBoston, MA
Brandon IngersollRelated PersonBoston, MA
Scott MacDonaldRelated PersonBoston, MA
Susan WhoriskeyRelated PersonBoston, MA
Allan W GreenDirectorBoston, MA
Shawn W HillierExecutive OfficerBoston, MA
Albert W HolmanDirectorBoston, MA
Matthias W FriebeExecutive OfficerBoston, MA
John W HoppinDirectorBoston, MA
John W HoppinExecutive OfficerBoston, MA
Jacob W HestermanExecutive OfficerBoston, MA
John W BabichDirectorBoston, MA
John W BabichExecutive OfficerBoston, MA
Reed W MalleckExecutive OfficerBoston, MA
Scott W HolbrookDirectorBoston, MA
John W GarveyExecutive OfficerBoston, MA
Susan W WhoriskeyDirectorBoston, MA

Other filings by this issuer (1)

FiledFormOfferingSold
2023-12-21D$50.7M$50.7M

More